High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$12.1M
$12,114,155
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-10 | $2,076,532Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-10 | $1,342,909Large | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-10 | $1,246,235Large | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Monia Brett P
• CEO
10b5-1 SellΔOwn -32.5%
2026-03-09
$8,850,642Whale
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 SellΔOwn -32.5%
|
2026-03-09 | $8,850,642Whale | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-09 | $4,477,181Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-09 | $2,485,652Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-09 | $547,087 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-09 | $127,282 | S | Form 4 |